A Trademark

Trademark Overview

On Wednesday, January 13, 2021, a trademark application was filed for A with the United States Patent and Trademark Office. The USPTO has given the A trademark a serial number of 90980594. The federal status of this trademark filing is REGISTERED as of Tuesday, January 9, 2024. This trademark is owned by Atsena Therapeutics, Inc.. The A trademark is filed in the Pharmaceutical Products category with the following description:

Gene therapy pharmaceutical preparations, namely, adeno-associated virus gene therapies for treatment of ocular disorders
a

General Information

Serial Number90980594
Word MarkA
Filing DateWednesday, January 13, 2021
Status700 - REGISTERED
Status DateTuesday, January 9, 2024
Registration Number7270457
Registration DateTuesday, January 9, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 31, 2021

Trademark Statements

Description of MarkThe mark consists of stylized "A" in the center of a circle.
Goods and ServicesGene therapy pharmaceutical preparations, namely, adeno-associated virus gene therapies for treatment of ocular disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 14, 2021
Primary Code005
First Use Anywhere DateMonday, July 31, 2023
First Use In Commerce DateMonday, July 31, 2023

Trademark Owner History

Party NameAtsena Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27709
Party NameAtsena Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27709
Party NameAtsena Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27701

Trademark Events

Event DateEvent Description
Tuesday, January 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 9, 2024REGISTERED-PRINCIPAL REGISTER
Friday, December 8, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 7, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 3, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, November 2, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 26, 2023USE AMENDMENT FILED
Thursday, November 2, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, October 26, 2023DIVISIONAL REQUEST RECEIVED
Thursday, October 26, 2023TEAS REQUEST TO DIVIDE RECEIVED
Thursday, November 2, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 26, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 26, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, April 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 25, 2023SOU EXTENSION 3 GRANTED
Tuesday, April 25, 2023SOU EXTENSION 3 FILED
Tuesday, April 25, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 26, 2022SOU EXTENSION 2 GRANTED
Wednesday, October 26, 2022SOU EXTENSION 2 FILED
Wednesday, October 26, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 10, 2022ASSIGNED TO EXAMINER
Saturday, April 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 21, 2022SOU EXTENSION 1 GRANTED
Thursday, April 21, 2022SOU EXTENSION 1 FILED
Thursday, April 21, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 26, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 31, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 31, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 11, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 22, 2021ASSIGNED TO EXAMINER
Wednesday, April 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 16, 2021NEW APPLICATION ENTERED

Related Keywords

gene therapies treatment ocular disorders virus adeno therapy pharmaceutical preparations